HIN accelerates operational efficiency and scales digital healthcare services with a resilient foundation powered by Red Hat OpenShiftATLANTA – RED HAT SUMMIT--(BUSINESS WIRE)--Red Hat, the world’s leading provider of open source solutions, today anno...
LONDON--(BUSINESS WIRE)--#aginginplace--The Health Impact Alliance (HIA) today announced it has partnered with Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY), a world leader in semiconductor solutions, to develop advanced connectivity solutions for...
Succeeds Co-Interim CEOs Michael Hooks, who will remain Chairman of the Board, and James Rushing, who will remain Chief Financial Officer and Executive Vice PresidentMALVERN, Pa.--(BUSINESS WIRE)--LifeScan (the "Company"), a world leader in blood gluc...
For the first time, consumers can discuss all prescription cost options using a simple, conversational experience built as infrastructure, not just a savings appNASHVILLE, Tenn.--(BUSINESS WIRE)--#AI--RxUtility, the medication affordability platform, ...
IRVINE, Calif.--(BUSINESS WIRE)--The Board of Directors of Precision Digital Health (PDH) is pleased to announce the appointment of Connie Pearcy as Chief Executive Officer. Connie most recently served as Chief Operating Officer at CREO, a life science...
Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS WIRE)--Sequenex today announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology co...
Partnership connects UberDoc's direct-pay specialist marketplace with XY.AI Labs' agentic platform, giving independent practices a vetted path to integrating AI and direct payBOSTON--(BUSINESS WIRE)--UberDoc Health Technologies Corp. (CSE: APPT | FSE:...
HOUSTON--(BUSINESS WIRE)--TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, today announced a $150K pre-seed investment from Caduceus Capital Partners and its selection into the Caduceus LAU...
Transaction extends CareDx’s Precision Medicine Testing Services strategy into specialty oncology with a Medicare-reimbursed commercial-stage MRD test and platform addressing a $4.5 Billion TAM Estimated 2025 Revenue of $34 Million is expected to grow...
EHR-enabled access has the potential to streamline ordering, accelerate clinical decisions, and drive scalable precision oncology adoptionFORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic sol...